The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials Review

Roy, Upal, Rodriguez, Jesse, Barber, Paul et al. (2015). The potential of HIV-1 nanotherapeutics: from in vitro studies to clinical trials . Nanomedicine, 10(24), 3597-3609. 10.2217/nnm.15.160

Open Access International Collaboration

cited authors

  • Roy, Upal; Rodriguez, Jesse; Barber, Paul; das Neves, Jose; Sarmento, Bruno; Nair, Madhavan

sustainable development goals

authors

publication date

  • January 1, 2015

published in

keywords

  • AIDS
  • Biotechnology & Applied Microbiology
  • DAPIVIRINE-LOADED NANOPARTICLES
  • DRUG-DELIVERY
  • GEL VIVAGEL
  • HIV
  • INFECTED PATIENTS
  • Life Sciences & Biomedicine
  • MICROBICIDE
  • NANOFORMULATED ANTIRETROVIRAL THERAPY
  • Nanoscience & Nanotechnology
  • POLYMERIC NANOPARTICLES
  • PREVENTION
  • SPL7013 GEL
  • Science & Technology
  • Science & Technology - Other Topics
  • TENOFOVIR
  • cART
  • nanomedicine
  • nanoparticles

Digital Object Identifier (DOI)

start page

  • 3597

end page

  • 3609

volume

  • 10

issue

  • 24